Virani Shafique — SEC Form 4 filings
SEC reporting owner CIK 1856081. 1 Form 4 filing on record with FilingPulse; latest filed 2024-01-18.
Transaction summary — filings shown
Covers all 1 filing on record, filed 2024-01-18 to 2024-01-18. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 1 leg across 1 filing — 18,000 shares, $196,740 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 2.
- Largest priced transaction: sale of 18,000 shares @ $10.93 ($196,740) in RECURSION PHARMACEUTICALS, INC., filed 2024-01-18.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| RECURSION PHARMACEUTICALS, INC. (RXRX) | Chief Business Officer | 1 | — | 1 leg · 18,000 sh · $196,740 | 2 |
Form 4 filings — Virani Shafique
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2024-01-18 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Option exercise (M): 18,000 @ $2.22 · Sale (S): 18,000 @ $10.93 · Option exercise (M): 18,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1856081 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →